Changing the world

UCLB is the commercialisation company of UCL. We bring to market truly world-leading, world-changing technologies, innovations that have a real and positive impact on people’s lives.

Find out more



Apollo Therapeutics wins KE Deal of the Year

Apollo Therapeutics received recognition at the Praxis Auril KE Awards 2021, picking up Deal of the Year, for attracting major investment to empower a unique, multi-university portfolio-based biopharmaceuticals venture.

Read more News



Curative gene therapies in sight

A gene therapy company formed from a UCLB spinout is developing potentially curative treatments for debilitating eye diseases including X-linked retinitis pigmentosa.

Read more case studies